CAPLACIZUMAB

CAPLACIZUMAB was reported 1784 times

CAPLACIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADAMTS13 INHIBITOR SCREEN ASSAY 3 1.0000
1 ADAMTS13 ACTIVITY ASSAY 1 1.0000
2 ADAMTS13 ACTIVITY ABNORMAL 73 0.8022
3 PLACENTAL OEDEMA 8 0.7273
4 ADAMTS13 ACTIVITY DECREASED 161 0.6216
5 ADAMTS13 ACTIVITY INCREASED 4 0.5000
6 HAEMORRHAGIC PANCREATIC CYST 1 0.5000
7 POST TRANSFUSION PURPURA 2 0.2500
8 SPLENIC ARTERY EMBOLISATION 1 0.1429
9 STRESS ULCER HAEMORRHAGE 1 0.1250
10 COMPRESSION GARMENT APPLICATION 1 0.1111
11 RETICULOCYTE PERCENTAGE ABNORMAL 1 0.1000
12 BLOOD GLUCAGON DECREASED 1 0.0833
13 SEPTIC PHLEBITIS 1 0.0769
14 RED BLOOD CELL ANISOCYTES PRESENT 1 0.0714
15 STOMATOCYTES PRESENT 1 0.0714
16 RED BLOOD CELL MICROCYTES PRESENT 1 0.0667
17 TRANSFERRIN SATURATION ABNORMAL 1 0.0588
18 RED BLOOD CELL POIKILOCYTES PRESENT 1 0.0556
19 FACTOR VIII ACTIVITY INCREASED 1 0.0526
20 EMBOLIC CEREBELLAR INFARCTION 1 0.0476
21 MONOCYTE PERCENTAGE ABNORMAL 1 0.0455
22 LYMPHOCYTE PERCENTAGE ABNORMAL 3 0.0435
23 MEDICAL DEVICE SITE PRURITUS 1 0.0370
24 POSTERIOR TIBIAL TENDON DYSFUNCTION 1 0.0357
25 INHIBITING ANTIBODIES 2 0.0286
26 PERIPHERAL VEIN THROMBUS EXTENSION 1 0.0256
27 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 4 0.0248
28 THROMBOTIC THROMBOCYTOPENIC PURPURA 84 0.0238
29 PROSTATIC DYSPLASIA 1 0.0222
30 HEPATITIS E VIRUS TEST POSITIVE 1 0.0217
31 HAPTOGLOBIN ABNORMAL 2 0.0217
32 RED CELL DISTRIBUTION WIDTH ABNORMAL 4 0.0211
33 CARDIAC PERFUSION DEFECT 1 0.0189
34 RETICULOCYTE COUNT ABNORMAL 2 0.0179
35 HAEMOGLOBINAEMIA 3 0.0175
36 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1 0.0164
37 BRONCHOALVEOLAR LAVAGE 1 0.0164
38 GRANULOCYTES ABNORMAL 3 0.0149
39 MEAN CELL VOLUME ABNORMAL 7 0.0148
40 EYELID HAEMATOMA 1 0.0147
41 PARVOVIRUS B19 TEST POSITIVE 1 0.0141
42 BLOOD LACTATE DEHYDROGENASE ABNORMAL 9 0.0133
43 MEAN PLATELET VOLUME ABNORMAL 1 0.0125
44 BLOOD CHLORIDE ABNORMAL 2 0.0123
45 MUCOSAL PAIN 1 0.0119
46 SCHISTOCYTOSIS 1 0.0115
47 PLATELET AGGREGATION 1 0.0114
48 HUMORAL IMMUNE DEFECT 4 0.0108
49 LIP SCAB 1 0.0103
50 ORAL BLOOD BLISTER 2 0.0100
51 SIGNET-RING CELL CARCINOMA 1 0.0100
52 BLEEDING TIME ABNORMAL 1 0.0097
53 INJECTION SITE PLAQUE 2 0.0095
54 RED BLOOD CELL SCHISTOCYTES PRESENT 3 0.0093
55 BLOOD LACTATE DEHYDROGENASE DECREASED 3 0.0090
56 PARANASAL SINUS HAEMORRHAGE 1 0.0090
57 NUCLEATED RED CELLS 1 0.0089
58 PLATELET COUNT ABNORMAL 47 0.0078
59 PREMENSTRUAL PAIN 1 0.0076
60 PLACENTAL INSUFFICIENCY 6 0.0075
61 GENITAL INJURY 1 0.0075
62 HAEMATOCRIT ABNORMAL 9 0.0073
63 ALBUMIN GLOBULIN RATIO INCREASED 1 0.0073
64 INJECTION SITE DERMATITIS 1 0.0069
65 HAIR GROWTH RATE ABNORMAL 1 0.0068
66 MUSCLE TONE DISORDER 2 0.0064
67 CARBON DIOXIDE ABNORMAL 2 0.0064
68 RED BLOOD CELL COUNT ABNORMAL 9 0.0061
69 INTESTINAL GANGRENE 1 0.0059
70 MULTISYSTEM INFLAMMATORY SYNDROME 1 0.0058
71 BENIGN RENAL NEOPLASM 1 0.0058
72 ABNORMAL MENSTRUAL CLOTS 1 0.0057
73 INJECTION SITE EROSION 2 0.0057
74 SUBCHORIONIC HAEMATOMA 1 0.0057
75 COMPLEMENT FACTOR DECREASED 1 0.0056
76 TRANCE 2 0.0055
77 AEROMONAS INFECTION 1 0.0053
78 HAEMOFILTRATION 1 0.0053
79 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2 0.0053
80 OPHTHALMIC HERPES SIMPLEX 3 0.0052
81 ACINETOBACTER TEST POSITIVE 1 0.0052
82 STENT REMOVAL 1 0.0051
83 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
84 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 3 0.0050
85 CATHETER SITE HAEMORRHAGE 12 0.0048
86 SUBCAPSULAR RENAL HAEMATOMA 1 0.0047
87 ROCKY MOUNTAIN SPOTTED FEVER 1 0.0047
88 THROMBOLYSIS 1 0.0045
89 MONOCYTE COUNT ABNORMAL 1 0.0045
90 MUCOSAL HAEMORRHAGE 5 0.0043
91 CENTRAL VENOUS CATHETER REMOVAL 2 0.0043
92 ENTEROBACTER TEST POSITIVE 1 0.0041
93 SERRATIA INFECTION 3 0.0040
94 STEROID DIABETES 6 0.0040
95 CHRONIC DISEASE 1 0.0039
96 LACK OF SATIETY 1 0.0038
97 IMMUNOGLOBULINS ABNORMAL 1 0.0038
98 HAPTOGLOBIN DECREASED 3 0.0037
99 RETICULOCYTE COUNT INCREASED 3 0.0037
100 CATHETER SITE THROMBOSIS 1 0.0036
101 NEUROLOGIC NEGLECT SYNDROME 2 0.0036
102 PLATELET DYSFUNCTION 1 0.0036
103 GINGIVAL BLEEDING 49 0.0036
104 MEAN PLATELET VOLUME DECREASED 3 0.0036
105 IMMATURE GRANULOCYTE COUNT INCREASED 1 0.0035
106 MEDICAL DEVICE SITE HAEMORRHAGE 1 0.0035
107 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
108 CATHETER SITE HAEMATOMA 1 0.0034
109 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 7 0.0034
110 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
111 POLYCHROMASIA 1 0.0033
112 HYDROPS FOETALIS 2 0.0033
113 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
114 BRONCHIAL HAEMORRHAGE 1 0.0032
115 PLATELET COUNT INCREASED 41 0.0031
116 INJECTION SITE SCAB 3 0.0031
117 CATHETER SITE BRUISE 1 0.0030
118 SERUM SICKNESS 8 0.0029
119 CATHETER REMOVAL 1 0.0028
120 PLASMABLASTIC LYMPHOMA 1 0.0028
121 ANTIBODY TEST ABNORMAL 2 0.0028
122 CEREBRAL MASS EFFECT 1 0.0028
123 OLIGOHYDRAMNIOS 9 0.0027
124 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 1 0.0027
125 TRAUMATIC HAEMORRHAGE 5 0.0027
126 HEAVY MENSTRUAL BLEEDING 23 0.0026
127 PREGNANCY TEST POSITIVE 1 0.0025
128 PRODUCT USE IN UNAPPROVED INDICATION 619 0.0025
129 BLEEDING TIME PROLONGED 3 0.0025
130 CRANIOTOMY 1 0.0024
131 GASTROENTERITIS SALMONELLA 2 0.0024
132 FOETAL DISTRESS SYNDROME 5 0.0024
133 LIP HAEMORRHAGE 3 0.0024
134 FRONTOTEMPORAL DEMENTIA 1 0.0023
135 HAEMOGLOBIN ABNORMAL 15 0.0023
136 SYSTOLIC HYPERTENSION 1 0.0023
137 CEREBRAL MICROHAEMORRHAGE 1 0.0022
138 BLOOD UREA ABNORMAL 2 0.0021
139 AIR EMBOLISM 1 0.0021
140 HYPERMETROPIA 2 0.0021
141 BLOOD IRON ABNORMAL 2 0.0020
142 HYPERCREATININAEMIA 1 0.0020
143 SPLENIC VEIN THROMBOSIS 1 0.0020
144 BLOOD ALBUMIN ABNORMAL 1 0.0019
145 PLASMAPHERESIS 1 0.0019
146 ABDOMINAL INJURY 1 0.0019
147 HAEMORRHAGIC INFARCTION 1 0.0018
148 MEAN CELL HAEMOGLOBIN INCREASED 3 0.0018
149 CARDIOSPASM 1 0.0018
150 EPISTAXIS 133 0.0018
151 ENCEPHALOMALACIA 1 0.0018
152 NAIL BED BLEEDING 1 0.0018
153 PHLEBITIS 9 0.0018
154 SPLENECTOMY 2 0.0017
155 TRANSAMINASES ABNORMAL 1 0.0017
156 OSTEOGENESIS IMPERFECTA 1 0.0017
157 THALAMIC INFARCTION 1 0.0017
158 MULTIMORBIDITY 2 0.0017
159 FOETAL GROWTH RESTRICTION 10 0.0016
160 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
161 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
162 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
163 SUBCUTANEOUS HAEMATOMA 2 0.0016
164 MEAN CELL VOLUME INCREASED 4 0.0016
165 PNEUMONIA NECROTISING 1 0.0015
166 IMMUNE THROMBOCYTOPENIA 7 0.0015
167 PNEUMOCOCCAL SEPSIS 1 0.0015
168 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
169 GINGIVAL DISCOMFORT 1 0.0015
170 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
171 SMALL INTESTINAL HAEMORRHAGE 3 0.0015
172 PARANEOPLASTIC SYNDROME 1 0.0015
173 THROMBOCYTOPENIC PURPURA 2 0.0015
174 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
175 SUTURE RELATED COMPLICATION 1 0.0014
176 NEUTROPHIL COUNT ABNORMAL 4 0.0014
177 MONOCYTE PERCENTAGE INCREASED 1 0.0014
178 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
179 INFUSION SITE BRUISING 3 0.0014
180 BACTERIAL DISEASE CARRIER 1 0.0014
181 HEMIANOPIA HOMONYMOUS 1 0.0014
182 THROMBOCYTOSIS 5 0.0014
183 SPONTANEOUS HAEMATOMA 1 0.0013
184 GINGIVAL ULCERATION 1 0.0013
185 TRACHEITIS 1 0.0013
186 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
187 ASPIRATION PLEURAL CAVITY 1 0.0013
188 PANCREATIC PSEUDOCYST 1 0.0013
189 CRITICAL ILLNESS 1 0.0013
190 INFECTION PARASITIC 1 0.0013
191 BLOOD FIBRINOGEN INCREASED 1 0.0013
192 PRE-ECLAMPSIA 6 0.0013
193 HAEMOPERITONEUM 1 0.0012
194 PLATELET COUNT DECREASED 133 0.0012
195 SHOULDER FRACTURE 2 0.0012
196 ANTIBODY TEST POSITIVE 2 0.0012
197 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
198 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
199 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
200 POST PROCEDURAL HAEMATOMA 2 0.0012
201 INJECTION SITE COLDNESS 1 0.0012
202 VITAL FUNCTIONS ABNORMAL 1 0.0012
203 ATONIC SEIZURES 1 0.0012
204 VASOCONSTRICTION 1 0.0011
205 TRANSFUSION REACTION 1 0.0011
206 TERMINAL INSOMNIA 2 0.0011
207 FIBRIN D DIMER INCREASED 4 0.0011
208 BLOOD ALBUMIN INCREASED 1 0.0011
209 CANDIDA SEPSIS 1 0.0011
210 INJECTION SITE DRYNESS 1 0.0011
211 INTESTINAL INFARCTION 1 0.0011
212 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
213 FOETAL HEART RATE ABNORMAL 1 0.0011
214 CATHETER SITE SWELLING 1 0.0011
215 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
216 ELECTROCARDIOGRAM CHANGE 1 0.0011
217 TROPONIN INCREASED 8 0.0011
218 VAGINAL DISORDER 1 0.0010
219 RED BLOOD CELL ABNORMALITY 1 0.0010
220 DISCOLOURED VOMIT 1 0.0010
221 BLOOD URINE 1 0.0010
222 APPLICATION SITE BRUISE 1 0.0010
223 ABDOMINAL WALL HAEMATOMA 2 0.0010
224 HEPARIN-INDUCED THROMBOCYTOPENIA 5 0.0010
225 CARDIAC ANEURYSM 1 0.0010
226 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
227 BRAIN HYPOXIA 1 0.0010
228 EMBOLISM VENOUS 3 0.0010
229 GASTRIC PH DECREASED 1 0.0010
230 CORONAVIRUS TEST POSITIVE 1 0.0010
231 FOETAL DEATH 5 0.0010
232 MOUTH HAEMORRHAGE 7 0.0010
233 CARPAL TUNNEL DECOMPRESSION 1 0.0009
234 CEREBRAL ARTERY OCCLUSION 1 0.0009
235 FOOD POISONING 5 0.0009
236 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
237 LYMPHOCYTOSIS 2 0.0009
238 SOMATIC SYMPTOM DISORDER 1 0.0009
239 CONTUSION 89 0.0009
240 INFUSION SITE HAEMORRHAGE 3 0.0009
241 EPSTEIN-BARR VIRAEMIA 1 0.0009
242 INTERMENSTRUAL BLEEDING 5 0.0009
243 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
244 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
245 INJECTION SITE BRUISING 70 0.0009
246 ARTERIAL HAEMORRHAGE 1 0.0009
247 PUPILS UNEQUAL 1 0.0009
248 ADMINISTRATION SITE PAIN 1 0.0009
249 AORTIC THROMBOSIS 1 0.0009
250 PETECHIAE 9 0.0009
251 RECTAL ULCER 1 0.0009
252 ISCHAEMIC STROKE 15 0.0008
253 FULL BLOOD COUNT INCREASED 1 0.0008
254 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
255 LACUNAR INFARCTION 2 0.0008
256 HAEMATOCRIT DECREASED 16 0.0008
257 ABDOMINAL TENDERNESS 4 0.0008
258 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
259 HAEMOLYTIC ANAEMIA 7 0.0008
260 ORGAN FAILURE 3 0.0007
261 SUBDURAL HAEMORRHAGE 2 0.0007
262 ABSCESS ORAL 1 0.0007
263 CORNEAL ABRASION 1 0.0007
264 RED BLOOD CELL COUNT INCREASED 2 0.0007
265 NASAL DISCHARGE DISCOLOURATION 1 0.0007
266 DISCHARGE 1 0.0007
267 LUNG CONSOLIDATION 2 0.0007
268 ANAL HAEMORRHAGE 2 0.0007
269 CULTURE URINE POSITIVE 1 0.0007
270 ALVEOLITIS 1 0.0007
271 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
272 TRACHEOSTOMY 1 0.0007
273 PELVIC VENOUS THROMBOSIS 1 0.0007
274 RENAL INFARCT 1 0.0007
275 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
276 NONINFECTIVE GINGIVITIS 1 0.0007
277 FAT TISSUE INCREASED 1 0.0007
278 BRAIN HERNIATION 2 0.0007
279 MYOCLONIC EPILEPSY 1 0.0007
280 MOUTH INJURY 1 0.0007
281 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
282 INJECTION SITE PARAESTHESIA 1 0.0007
283 COITAL BLEEDING 1 0.0006
284 INJECTION SITE HYPERSENSITIVITY 2 0.0006
285 SKIN ABRASION 3 0.0006
286 INTERMITTENT CLAUDICATION 1 0.0006
287 GINGIVAL PAIN 5 0.0006
288 CUSHINGOID 2 0.0006
289 INCOHERENT 4 0.0006
290 THROMBOTIC MICROANGIOPATHY 6 0.0006
291 SHOCK HAEMORRHAGIC 5 0.0006
292 BRADYPHRENIA 4 0.0006
293 VASOPLEGIA SYNDROME 1 0.0006
294 PRODUCT PREPARATION ISSUE 4 0.0006
295 SUSPECTED COVID-19 2 0.0006
296 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
297 ARTHROPOD STING 1 0.0006
298 MITRAL VALVE PROLAPSE 1 0.0006
299 CEREBELLAR INFARCTION 1 0.0006
300 SPLEEN DISORDER 1 0.0006
301 INJECTION SITE RASH 18 0.0006
302 INJECTION SITE OEDEMA 1 0.0006
303 MILIARIA 1 0.0006
304 BLOOD CHLORIDE INCREASED 1 0.0006
305 BLOOD CREATININE ABNORMAL 2 0.0006
306 SPLENIC INFARCTION 1 0.0006
307 OTORRHOEA 1 0.0006
308 LACK OF INJECTION SITE ROTATION 1 0.0006
309 JUGULAR VEIN THROMBOSIS 1 0.0006
310 HAEMORRHAGIC DIATHESIS 2 0.0006
311 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
312 INJECTION SITE DISCOLOURATION 7 0.0006
313 MONOCYTE COUNT INCREASED 2 0.0006
314 SKIN HAEMORRHAGE 8 0.0005
315 STENOSIS 1 0.0005
316 HAEMOLYSIS 4 0.0005
317 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
318 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
319 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
320 PSYCHIATRIC DECOMPENSATION 1 0.0005
321 WOUND SECRETION 2 0.0005
322 BICYTOPENIA 1 0.0005
323 MULTI-ORGAN DISORDER 1 0.0005
324 LABORATORY TEST ABNORMAL 15 0.0005
325 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
326 HYPERPHAGIA 2 0.0005
327 EAR HAEMORRHAGE 1 0.0005
328 BODY TEMPERATURE INCREASED 10 0.0005
329 QUADRIPLEGIA 1 0.0005
330 VENOUS THROMBOSIS LIMB 1 0.0005
331 ATRIAL THROMBOSIS 1 0.0005
332 DISEASE RECURRENCE 23 0.0005
333 MENSTRUAL DISORDER 4 0.0005
334 NASAL DRYNESS 3 0.0005
335 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
336 INJECTION SITE IRRITATION 6 0.0005
337 CHAPPED LIPS 2 0.0005
338 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
339 HAEMORRHAGE 48 0.0005
340 HAEMOGLOBIN DECREASED 47 0.0005
341 PURPURA 4 0.0005
342 POSTOPERATIVE WOUND INFECTION 3 0.0004
343 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
344 HAEMATOCRIT INCREASED 1 0.0004
345 PANCREATITIS NECROTISING 1 0.0004
346 NEUROLOGICAL DECOMPENSATION 1 0.0004
347 PERFORMANCE STATUS DECREASED 2 0.0004
348 DISCOURAGEMENT 1 0.0004
349 PUSTULE 1 0.0004
350 EOSINOPHIL COUNT DECREASED 1 0.0004
351 SUBDURAL HAEMATOMA 6 0.0004
352 CEREBRAL HAEMORRHAGE 15 0.0004
353 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
354 GLOMERULONEPHRITIS 1 0.0004
355 DERMAL CYST 1 0.0004
356 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
357 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
358 INJECTION SITE INFLAMMATION 2 0.0004
359 HAEMORRHAGE INTRACRANIAL 6 0.0004
360 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
361 SYSTEMIC CANDIDA 1 0.0004
362 PLATELET DISORDER 1 0.0004
363 HAEMOPTYSIS 11 0.0004
364 SUBARACHNOID HAEMORRHAGE 4 0.0004
365 VAGINAL HAEMORRHAGE 17 0.0004
366 NEUTROPHIL COUNT INCREASED 4 0.0004
367 INJECTION SITE HAEMORRHAGE 31 0.0004
368 BLOOD CHLORIDE DECREASED 1 0.0004
369 HAEMATOMA 10 0.0004
370 CATHETER SITE PAIN 1 0.0004
371 PULMONARY HAEMORRHAGE 3 0.0004
372 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
373 URINE OUTPUT INCREASED 1 0.0004
374 TRANSFUSION 4 0.0004
375 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
376 LUNG OPACITY 1 0.0004
377 BLOOD POTASSIUM ABNORMAL 1 0.0004
378 STEATORRHOEA 1 0.0004
379 RECTAL HAEMORRHAGE 16 0.0004
380 LARYNGOSPASM 1 0.0004
381 GASTROINTESTINAL INJURY 1 0.0004
382 ABDOMINAL RIGIDITY 1 0.0004
383 MOOD ALTERED 10 0.0004
384 HEMIPLEGIA 3 0.0004
385 HAEMORRHOIDS 7 0.0004
386 HEART RATE ABNORMAL 2 0.0004
387 INJECTION SITE PRURITUS 24 0.0004
388 HAEMATEMESIS 9 0.0004
389 REBOUND EFFECT 4 0.0004
390 DIALYSIS 5 0.0004
391 INTERNAL HAEMORRHAGE 4 0.0003
392 RED BLOOD CELL COUNT DECREASED 10 0.0003
393 POST PROCEDURAL HAEMORRHAGE 4 0.0003
394 URINE ODOUR ABNORMAL 2 0.0003
395 GROWTH RETARDATION 1 0.0003
396 DEEP VEIN THROMBOSIS 22 0.0003
397 BACTERAEMIA 4 0.0003
398 THROMBOSIS 27 0.0003
399 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
400 HYPERCAPNIA 1 0.0003
401 HIV INFECTION 1 0.0003
402 CENTRAL VENOUS CATHETERISATION 1 0.0003
403 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
404 CEREBRAL INFARCTION 8 0.0003
405 DUODENITIS 1 0.0003
406 INTRACARDIAC THROMBUS 1 0.0003
407 HOSPITALISATION 50 0.0003
408 PIGMENTATION DISORDER 2 0.0003
409 FAECES DISCOLOURED 7 0.0003
410 BLOOD BLISTER 1 0.0003
411 BLOOD CREATININE DECREASED 1 0.0003
412 BRAIN OEDEMA 4 0.0003
413 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
414 BILE DUCT STONE 1 0.0003
415 PNEUMONIA VIRAL 1 0.0003
416 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
417 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
418 PHARYNGEAL SWELLING 3 0.0003
419 MENORRHAGIA 6 0.0003
420 PERICARDIAL EFFUSION 7 0.0003
421 ANXIETY DISORDER 1 0.0003
422 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
423 ECCHYMOSIS 2 0.0003
424 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
425 RASH MACULAR 10 0.0003
426 EMBOLIC STROKE 1 0.0003
427 SKIN REACTION 4 0.0003
428 LYMPHOCYTE COUNT DECREASED 5 0.0003
429 PRODUCT CONTAMINATION 1 0.0003
430 SKIN WEEPING 1 0.0003
431 DECREASED ACTIVITY 3 0.0003
432 BLOOD PHOSPHORUS DECREASED 1 0.0003
433 MELAENA 6 0.0003
434 RECTAL DISCHARGE 1 0.0003
435 BLOOD GLUCOSE ABNORMAL 5 0.0003
436 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
437 INJECTION SITE PAIN 82 0.0003
438 CHROMATURIA 6 0.0003
439 PROTEIN TOTAL DECREASED 1 0.0003
440 SNORING 1 0.0003
441 PRODUCT STORAGE ISSUE 1 0.0003
442 CONDITION AGGRAVATED 80 0.0003
443 MENSTRUATION IRREGULAR 7 0.0003
444 GINGIVAL DISORDER 1 0.0003
445 DEVICE RELATED INFECTION 4 0.0003
446 INJECTION SITE ERYTHEMA 32 0.0003
447 RHINOVIRUS INFECTION 1 0.0003
448 CARDIOPULMONARY FAILURE 1 0.0003
449 NERVOUS SYSTEM DISORDER 8 0.0003
450 HAEMORRHAGIC STROKE 2 0.0003
451 BRAIN FOG 4 0.0003
452 PNEUMONIA FUNGAL 1 0.0003
453 BLOOD IRON DECREASED 3 0.0003
454 FURUNCLE 2 0.0003
455 NASAL DISCOMFORT 2 0.0003
456 BLOOD ALBUMIN DECREASED 2 0.0003
457 OBESITY 4 0.0003
458 OESOPHAGEAL CANDIDIASIS 1 0.0003
459 BLOOD DISORDER 2 0.0002
460 CYSTITIS HAEMORRHAGIC 1 0.0002
461 VITAMIN B12 DEFICIENCY 1 0.0002
462 INJECTION SITE URTICARIA 6 0.0002
463 GOITRE 1 0.0002
464 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
465 INJECTION SITE EXTRAVASATION 3 0.0002
466 HAEMODIALYSIS 2 0.0002
467 OFF LABEL USE 208 0.0002
468 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
469 HEMIPARESIS 4 0.0002
470 MUSCLE FATIGUE 1 0.0002
471 HAEMATOCHEZIA 13 0.0002
472 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
473 HEPATIC PAIN 1 0.0002
474 VITAMIN D DECREASED 2 0.0002
475 PRODUCT DISPENSING ISSUE 1 0.0002
476 BLOOD POTASSIUM DECREASED 7 0.0002
477 SKIN SWELLING 2 0.0002
478 NEUROTOXICITY 4 0.0002
479 ORAL CANDIDIASIS 3 0.0002
480 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
481 LYMPHADENOPATHY 8 0.0002
482 UNEVALUABLE EVENT 17 0.0002
483 THROMBOCYTOPENIA 25 0.0002
484 IRON DEFICIENCY 1 0.0002
485 URINARY TRACT DISORDER 1 0.0002
486 HAEMOGLOBIN INCREASED 1 0.0002
487 DISEASE COMPLICATION 1 0.0002
488 EAR DISORDER 1 0.0002
489 ISCHAEMIA 1 0.0002
490 HUNGER 3 0.0002
491 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
492 BLOOD URINE PRESENT 4 0.0002
493 CARDIAC TAMPONADE 1 0.0002
494 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
495 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
496 HYPOVOLAEMIC SHOCK 1 0.0002
497 STILLBIRTH 1 0.0002
498 LIVER FUNCTION TEST ABNORMAL 6 0.0002
499 HAEMATURIA 7 0.0002
500 PANCREATIC DISORDER 1 0.0002
501 BLOOD PRESSURE ABNORMAL 4 0.0002
502 VEIN DISORDER 1 0.0002
503 KLEBSIELLA INFECTION 1 0.0002
504 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
505 TASTE DISORDER 4 0.0002
506 MOTOR DYSFUNCTION 2 0.0002
507 PETIT MAL EPILEPSY 1 0.0002
508 CEREBRAL ISCHAEMIA 1 0.0002
509 POLLAKIURIA 8 0.0002
510 SCRATCH 2 0.0002
511 SENSORY DISTURBANCE 3 0.0002
512 ANAL FISSURE 1 0.0002
513 THROAT TIGHTNESS 5 0.0002
514 SEPTIC SHOCK 8 0.0002
515 PALLOR 5 0.0002
516 ASTHENOPIA 1 0.0002
517 INTESTINAL ISCHAEMIA 1 0.0002
518 NECROSIS 1 0.0002
519 BLOOD UREA INCREASED 3 0.0002
520 ANGIOPATHY 1 0.0002
521 PRODUCT LEAKAGE 1 0.0002
522 MITRAL VALVE INCOMPETENCE 2 0.0002
523 CHOLECYSTITIS ACUTE 1 0.0002
524 METRORRHAGIA 3 0.0002
525 SCAB 2 0.0002
526 CORONARY ARTERY BYPASS 1 0.0002
527 GASTRIC HAEMORRHAGE 2 0.0002
528 SKIN WARM 1 0.0002
529 HYPOVOLAEMIA 1 0.0002
530 HYPERCHLORHYDRIA 1 0.0002
531 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
532 BRADYKINESIA 1 0.0002
533 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
534 THIRST 3 0.0002
535 CHOLECYSTITIS 2 0.0002
536 MYOCLONUS 2 0.0002
537 HEPATITIS B 1 0.0002
538 INJECTION SITE VESICLES 1 0.0002
539 DERMATITIS ACNEIFORM 1 0.0002
540 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
541 LARYNGEAL OEDEMA 1 0.0002
542 BACTERIAL INFECTION 3 0.0002
543 AGEUSIA 4 0.0002
544 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
545 PHOTOPHOBIA 3 0.0002
546 MUSCLE ATROPHY 2 0.0002
547 CARDIAC ARREST 13 0.0002
548 FEELING JITTERY 3 0.0002
549 INCREASED APPETITE 3 0.0002
550 SCREAMING 1 0.0002
551 MOOD SWINGS 5 0.0002
552 RENAL IMPAIRMENT 13 0.0002
553 HERPES SIMPLEX 1 0.0002
554 ORAL HERPES 3 0.0002
555 SKIN DISCOLOURATION 7 0.0002
556 SKIN MASS 1 0.0001
557 SPINAL FRACTURE 3 0.0001
558 PRODUCT ADMINISTRATION ERROR 3 0.0001
559 RASH PRURITIC 8 0.0001
560 LIMB INJURY 4 0.0001
561 NEPHROTIC SYNDROME 1 0.0001
562 RESPIRATION ABNORMAL 1 0.0001
563 ACNE 11 0.0001
564 DROOLING 1 0.0001
565 FORMICATION 1 0.0001
566 FATIGUE 111 0.0001
567 BLOOD TEST ABNORMAL 2 0.0001
568 HEPATOCELLULAR INJURY 2 0.0001
569 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
570 RETINAL HAEMORRHAGE 1 0.0001
571 FEAR OF INJECTION 1 0.0001
572 POOR QUALITY SLEEP 3 0.0001
573 PARAESTHESIA ORAL 2 0.0001
574 PANIC REACTION 1 0.0001
575 SWELLING FACE 9 0.0001
576 INJECTION SITE HAEMATOMA 2 0.0001
577 PRODUCT PRESCRIBING ISSUE 3 0.0001
578 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
579 DYSSTASIA 4 0.0001
580 PULMONARY EMBOLISM 13 0.0001
581 ORAL DISORDER 1 0.0001
582 SENSITIVE SKIN 1 0.0001
583 HYPOPHOSPHATAEMIA 1 0.0001
584 CEREBRAL DISORDER 1 0.0001
585 HEPATOTOXICITY 3 0.0001
586 ORAL PAIN 3 0.0001
587 RASH PAPULAR 3 0.0001
588 HYPOAESTHESIA ORAL 2 0.0001
589 HEADACHE 83 0.0001
590 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
591 AORTIC ANEURYSM 1 0.0001
592 HAEMODYNAMIC INSTABILITY 1 0.0001
593 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
594 THYROID DISORDER 2 0.0001
595 EMOTIONAL DISORDER 4 0.0001
596 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
597 ANAPHYLACTIC REACTION 7 0.0001
598 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
599 RASH ERYTHEMATOUS 6 0.0001
600 SENSORY LOSS 1 0.0001
601 FRUSTRATION TOLERANCE DECREASED 1 0.0001
602 MYALGIA 21 0.0001
603 BLOOD POTASSIUM INCREASED 2 0.0001
604 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
605 ASPHYXIA 1 0.0001
606 SEIZURE 14 0.0001
607 PARAESTHESIA 19 0.0001
608 ACUTE CORONARY SYNDROME 1 0.0001
609 EMBOLISM 1 0.0001
610 CYTOMEGALOVIRUS INFECTION 2 0.0001
611 MUSCLE SPASMS 22 0.0001
612 CANDIDA INFECTION 2 0.0001
613 CIRCULATORY COLLAPSE 2 0.0001
614 PRODUCT CONTAINER ISSUE 1 0.0001
615 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
616 CARDIAC OPERATION 1 0.0001
617 JOINT SWELLING 14 0.0001
618 MYOPATHY 1 0.0001
619 PYELONEPHRITIS 1 0.0001
620 GRIP STRENGTH DECREASED 1 0.0001
621 FACIAL PAIN 1 0.0001
622 HAEMARTHROSIS 1 0.0001
623 THERAPY NON-RESPONDER 5 0.0001
624 OSTEOMYELITIS 2 0.0001
625 ANAEMIA 21 0.0001
626 PNEUMONIA BACTERIAL 1 0.0001
627 INCREASED TENDENCY TO BRUISE 1 0.0001
628 OVARIAN CANCER 1 0.0001
629 IRON DEFICIENCY ANAEMIA 1 0.0001
630 MENTAL STATUS CHANGES 3 0.0001
631 FEELING COLD 3 0.0001
632 PERSONALITY CHANGE 1 0.0001
633 AGRANULOCYTOSIS 2 0.0001
634 BLOOD CREATININE INCREASED 7 0.0001
635 NEPHROPATHY 1 0.0001
636 DIARRHOEA HAEMORRHAGIC 1 0.0001
637 CEREBROVASCULAR ACCIDENT 18 0.0001
638 HOT FLUSH 8 0.0001
639 SPUTUM DISCOLOURED 1 0.0001
640 PRODUCT PACKAGING ISSUE 1 0.0001
641 GASTRIC ULCER 2 0.0001
642 INTENTIONAL DOSE OMISSION 3 0.0001
643 EYE INFLAMMATION 1 0.0001
644 INJECTION SITE SWELLING 8 0.0001
645 CHOLESTASIS 2 0.0001
646 AFFECT LABILITY 1 0.0001
647 INFECTION 15 0.0001
648 ARTHRALGIA 43 0.0001
649 PRODUCT STORAGE ERROR 9 0.0001
650 RENAL TUBULAR NECROSIS 1 0.0001
651 INJECTION SITE REACTION 7 0.0001
652 HOSPICE CARE 1 0.0001
653 SINUS DISORDER 2 0.0001
654 OVARIAN CYST 1 0.0001
655 PREGNANCY 2 0.0001
656 FULL BLOOD COUNT DECREASED 2 0.0001
657 THERAPEUTIC RESPONSE DECREASED 6 0.0001
658 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
659 ASTHENIA 37 0.0001
660 INSOMNIA 26 0.0001
661 PERIPHERAL SWELLING 15 0.0001
662 PRODUCT PREPARATION ERROR 2 0.0001
663 HELICOBACTER INFECTION 1 0.0001
664 LIMB DISCOMFORT 3 0.0001
665 TEMPERATURE INTOLERANCE 1 0.0001
666 HYPERBILIRUBINAEMIA 1 0.0001
667 TENDERNESS 1 0.0001
668 ABDOMINAL DISTENSION 10 0.0001
669 SPEECH DISORDER 5 0.0001
670 PYREXIA 33 0.0001
671 PRODUCT DOSE OMISSION ISSUE 28 0.0001
672 INJECTION SITE DISCOMFORT 1 0.0001
673 MOUTH ULCERATION 2 0.0001
674 JOINT DISLOCATION 1 0.0001
675 FULL BLOOD COUNT ABNORMAL 1 0.0001
676 RENAL PAIN 1 0.0001
677 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
678 MOVEMENT DISORDER 3 0.0001
679 NIGHT SWEATS 3 0.0001
680 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
681 MENSTRUATION DELAYED 1 0.0001
682 PRODUCT DOSE OMISSION 6 0.0001
683 PULMONARY THROMBOSIS 1 0.0001
684 ASPIRATION 1 0.0001
685 BLOOD GLUCOSE FLUCTUATION 1 0.0001
686 COVID-19 16 0.0001
687 TRANSAMINASES INCREASED 2 0.0001
688 HYPERTENSION 19 0.0001
689 RASH 39 0.0001
690 NEPHROPATHY TOXIC 1 0.0001
691 BLOOD CALCIUM DECREASED 1 0.0001
692 ILLNESS 9 0.0001
693 NEOPLASM 1 0.0001
694 BACK PAIN 20 0.0001
695 SWELLING 8 0.0001
696 SPLENOMEGALY 1 0.0001
697 CHILLS 10 0.0001
698 NASAL CONGESTION 5 0.0001
699 BLOOD GLUCOSE INCREASED 16 0.0001
700 COVID-19 PNEUMONIA 1 0.0001
701 COMA 4 0.0001
702 MOBILITY DECREASED 6 0.0001
703 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
704 IRRITABILITY 5 0.0001
705 LOCALISED INFECTION 2 0.0001
706 FEELING HOT 5 0.0001
707 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
708 ANXIETY 23 0.0001
709 GENERALISED OEDEMA 1 0.0001
710 SECRETION DISCHARGE 1 0.0001
711 DYSARTHRIA 3 0.0001
712 DERMATITIS ALLERGIC 1 0.0001
713 FEELING ABNORMAL 19 0.0001
714 HEPATIC CYTOLYSIS 1 0.0001
715 CONSTIPATION 17 0.0001
716 MYDRIASIS 1 0.0001
717 GENITAL HAEMORRHAGE 1 0.0001
718 SKIN ULCER 2 0.0001
719 INJECTION SITE INDURATION 1 0.0001
720 PALPITATIONS 9 0.0001
721 DEAFNESS 2 0.0001
722 BEDRIDDEN 1 0.0001
723 IMMUNE SYSTEM DISORDER 1 0.0001
724 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
725 SARS-COV-2 TEST POSITIVE 1 0.0001
726 DISORIENTATION 3 0.0001
727 DEPRESSED MOOD 4 0.0001
728 DYSMENORRHOEA 1 0.0001
729 HYPERSENSITIVITY 14 0.0001
730 ADVERSE REACTION 1 0.0001
731 BLOOD PRESSURE DECREASED 5 0.0001
732 EYE HAEMORRHAGE 1 0.0001
733 HAIR TEXTURE ABNORMAL 1 0.0001
734 SINUS CONGESTION 1 0.0001
735 MIGRAINE 7 0.0001
736 CORONARY ARTERY OCCLUSION 1 0.0001
737 SKIN LESION 2 0.0001
738 TREMOR 12 0.0001
739 INFLUENZA 8 0.0001
740 SEPSIS 8 0.0001
741 SEASONAL ALLERGY 1 0.0001
742 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
743 FLATULENCE 4 0.0001
744 CHEST PAIN 13 0.0001
745 PARALYSIS 1 0.0001
746 CARDIOGENIC SHOCK 1 0.0001
747 IMPAIRED QUALITY OF LIFE 1 0.0001
748 ANOSMIA 1 0.0001
749 DYSPNOEA 39 0.0001
750 HYPOKINESIA 1 0.0001
751 FLUID OVERLOAD 1 0.0001
752 BONE PAIN 4 0.0001
753 SURGERY 4 0.0001
754 AGITATION 5 0.0001
755 ACUTE MYOCARDIAL INFARCTION 2 0.0001
756 DISEASE PROGRESSION 8 0.0001
757 PULMONARY OEDEMA 3 0.0001
758 PREMATURE BABY 2 0.0001
759 APHASIA 2 0.0001
760 BLOOD COUNT ABNORMAL 1 0.0001
761 BLOOD PRESSURE INCREASED 10 0.0001
762 HIP ARTHROPLASTY 1 0.0001
763 PHARYNGEAL OEDEMA 1 0.0001
764 OROPHARYNGEAL PAIN 6 0.0001
765 MUSCULOSKELETAL CHEST PAIN 1 0.0001
766 RENAL DISORDER 3 0.0001
767 THERAPY PARTIAL RESPONDER 1 0.0001
768 OCULAR HYPERAEMIA 3 0.0001
769 HEAD INJURY 2 0.0001
770 PNEUMOTHORAX 1 0.0001
771 RESPIRATORY TRACT CONGESTION 1 0.0001
772 ULCER 1 0.0001
773 CYSTITIS 2 0.0001
774 PREMATURE DELIVERY 1 0.0001
775 SCIATICA 1 0.0001
776 HYPERHIDROSIS 8 0.0001
777 RHINORRHOEA 4 0.0001
778 BACK DISORDER 1 0.0001
779 LUNG DISORDER 3 0.0001
780 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
781 CHOLELITHIASIS 2 0.0001
782 STAPHYLOCOCCAL INFECTION 2 0.0001
783 PHOTOSENSITIVITY REACTION 1 0.0001
784 INFUSION RELATED REACTION 4 0.0001
785 PAIN 37 0.0001
786 FUNGAL INFECTION 2 0.0001
787 GAIT INABILITY 2 0.0001
788 FLUID RETENTION 3 0.0001
789 NEUTROPENIA 8 0.0001
790 PAIN IN EXTREMITY 17 0.0001
791 DELIRIUM 2 0.0001
792 ORTHOSTATIC HYPOTENSION 1 0.0001
793 SYRINGE ISSUE 1 0.0001
794 PANCREATITIS 3 0.0001
795 COLD SWEAT 1 0.0001
796 SLEEP DISORDER 4 0.0001
797 BRADYCARDIA 3 0.0001
798 HEAD DISCOMFORT 1 0.0001
799 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
800 TACHYCARDIA 5 0.0001
801 ADVERSE DRUG REACTION 5 0.0001
802 GASTROENTERITIS VIRAL 1 0.0001
803 CRYING 2 0.0001
804 C-REACTIVE PROTEIN INCREASED 2 0.0001
805 RESPIRATORY FAILURE 4 0.0001
806 CONJUNCTIVITIS 1 0.0001
807 URTICARIA 9 0.0001
808 OXYGEN SATURATION DECREASED 3 0.0001
809 DYSPNOEA EXERTIONAL 2 0.0001
810 BLOOD SODIUM DECREASED 1 0.0001
811 PROTEINURIA 1 0.0001
812 HERPES ZOSTER 3 0.0001
813 PRURITUS 20 0.0001
814 ACUTE RESPIRATORY FAILURE 1 0.0001
815 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
816 EAR PAIN 1 0.0001
817 DYSPHONIA 3 0.0001
818 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
819 DISABILITY 1 0.0001
820 ABORTION SPONTANEOUS 2 0.0000
821 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
822 NO ADVERSE EVENT 9 0.0000
823 PRODUCT PHYSICAL ISSUE 1 0.0000
824 INTENTIONAL SELF-INJURY 1 0.0000
825 DISCOMFORT 3 0.0000
826 INJURY ASSOCIATED WITH DEVICE 1 0.0000
827 BLINDNESS 2 0.0000
828 VISUAL IMPAIRMENT 6 0.0000
829 PULMONARY HYPERTENSION 1 0.0000
830 KNEE ARTHROPLASTY 1 0.0000
831 EATING DISORDER 1 0.0000
832 RETCHING 1 0.0000
833 IMPAIRED WORK ABILITY 1 0.0000
834 HYPOAESTHESIA 7 0.0000
835 LIVER FUNCTION TEST INCREASED 1 0.0000
836 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
837 ACUTE KIDNEY INJURY 7 0.0000
838 DEHYDRATION 6 0.0000
839 HEPATIC ENZYME INCREASED 3 0.0000
840 MUSCULAR WEAKNESS 5 0.0000
841 ERYTHEMA 9 0.0000
842 SKIN IRRITATION 2 0.0000
843 NEPHROLITHIASIS 2 0.0000
844 HYPOKALAEMIA 2 0.0000
845 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
846 PNEUMONIA 14 0.0000
847 ABDOMINAL PAIN 10 0.0000
848 BLOOD CHOLESTEROL INCREASED 2 0.0000
849 COUGH 12 0.0000
850 ARRHYTHMIA 2 0.0000
851 GAIT DISTURBANCE 8 0.0000
852 BLOOD PRESSURE FLUCTUATION 1 0.0000
853 DIABETIC KETOACIDOSIS 1 0.0000
854 PRESYNCOPE 1 0.0000
855 URINARY TRACT INFECTION 7 0.0000
856 ENCEPHALOPATHY 1 0.0000
857 DYSPEPSIA 4 0.0000
858 HEART RATE INCREASED 4 0.0000
859 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
860 WEIGHT INCREASED 9 0.0000
861 PNEUMONIA ASPIRATION 1 0.0000
862 CELLULITIS 2 0.0000
863 HEPATITIS 1 0.0000
864 CHEST DISCOMFORT 4 0.0000
865 ANAPHYLACTIC SHOCK 1 0.0000
866 MALAISE 17 0.0000
867 EXPOSURE VIA SKIN CONTACT 1 0.0000
868 RESPIRATORY TRACT INFECTION 1 0.0000
869 NERVOUSNESS 2 0.0000
870 JOINT STIFFNESS 1 0.0000
871 DIZZINESS 19 0.0000
872 GASTRITIS 1 0.0000
873 EAR INFECTION 1 0.0000
874 CARDIAC FAILURE 3 0.0000
875 PRODUCT USE ISSUE 7 0.0000
876 JAUNDICE 1 0.0000
877 CONFUSIONAL STATE 6 0.0000
878 FREQUENT BOWEL MOVEMENTS 1 0.0000
879 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
880 PRODUCT QUALITY ISSUE 5 0.0000
881 TREATMENT NONCOMPLIANCE 2 0.0000
882 MEMORY IMPAIRMENT 5 0.0000
883 ABNORMAL DREAMS 1 0.0000
884 PROCEDURAL PAIN 1 0.0000
885 PANCYTOPENIA 2 0.0000
886 BLISTER 2 0.0000
887 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
888 PAIN IN JAW 1 0.0000
889 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
890 INCORRECT DOSE ADMINISTERED 8 0.0000
891 HYPOTENSION 7 0.0000
892 HYPERSOMNIA 1 0.0000
893 BALANCE DISORDER 3 0.0000
894 PANCREATIC CARCINOMA 1 0.0000
895 INTENTIONAL PRODUCT MISUSE 3 0.0000
896 URINARY INCONTINENCE 1 0.0000
897 RESPIRATORY DISORDER 1 0.0000
898 HEPATIC FAILURE 1 0.0000
899 LACRIMATION INCREASED 1 0.0000
900 CORONARY ARTERY DISEASE 1 0.0000
901 PLEURAL EFFUSION 2 0.0000
902 EPILEPSY 1 0.0000
903 EXPOSURE DURING PREGNANCY 2 0.0000
904 CARDIAC DISORDER 3 0.0000
905 NEUROPATHY PERIPHERAL 3 0.0000
906 LACTIC ACIDOSIS 1 0.0000
907 AMNESIA 2 0.0000
908 IMPAIRED HEALING 1 0.0000
909 OSTEONECROSIS 1 0.0000
910 EYE DISORDER 1 0.0000
911 VIRAL INFECTION 1 0.0000
912 LIP SWELLING 1 0.0000
913 NEOPLASM MALIGNANT 2 0.0000
914 ABDOMINAL DISCOMFORT 5 0.0000
915 VOMITING 14 0.0000
916 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
917 ANGER 1 0.0000
918 FLUSHING 3 0.0000
919 ABDOMINAL PAIN UPPER 6 0.0000
920 VISION BLURRED 4 0.0000
921 BURNING SENSATION 2 0.0000
922 HYPERKALAEMIA 1 0.0000
923 HEART RATE DECREASED 1 0.0000
924 INJURY 2 0.0000
925 HYPOXIA 1 0.0000
926 HYPERGLYCAEMIA 1 0.0000
927 DYSURIA 1 0.0000
928 INJECTION SITE MASS 1 0.0000
929 HEPATIC FUNCTION ABNORMAL 1 0.0000
930 ASTHMA 3 0.0000
931 NAUSEA 21 0.0000
932 DEPRESSION 6 0.0000
933 DIABETES MELLITUS 2 0.0000
934 PLASMA CELL MYELOMA 1 0.0000
935 DRUG INEFFECTIVE 33 0.0000
936 SOMNOLENCE 5 0.0000
937 OEDEMA PERIPHERAL 3 0.0000
938 OSTEOPOROSIS 1 0.0000
939 FALL 8 0.0000
940 CARDIO-RESPIRATORY ARREST 1 0.0000
941 TOXICITY TO VARIOUS AGENTS 4 0.0000
942 LOSS OF CONSCIOUSNESS 3 0.0000
943 DIARRHOEA 15 0.0000
944 MENTAL DISORDER 1 0.0000
945 MYOCARDIAL INFARCTION 4 0.0000
946 DYSPHAGIA 2 0.0000
947 PRODUCTIVE COUGH 1 0.0000
948 BLOOD GLUCOSE DECREASED 1 0.0000
949 ATRIAL FIBRILLATION 2 0.0000
950 DEATH 17 0.0000
951 SINUSITIS 2 0.0000
952 INFLAMMATION 1 0.0000
953 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
954 ECZEMA 1 0.0000
955 DISTURBANCE IN ATTENTION 1 0.0000
956 OEDEMA 1 0.0000
957 MEDICATION ERROR 1 0.0000
958 WEIGHT DECREASED 5 0.0000
959 EYE PAIN 1 0.0000
960 LETHARGY 1 0.0000
961 CATARACT 1 0.0000
962 ILL-DEFINED DISORDER 1 0.0000
963 VERTIGO 1 0.0000
964 FEBRILE NEUTROPENIA 1 0.0000
965 DRY SKIN 2 0.0000
966 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
967 THERAPY INTERRUPTED 1 0.0000
968 BRONCHITIS 1 0.0000
969 DYSGEUSIA 1 0.0000
970 HALLUCINATION 1 0.0000
971 CHRONIC KIDNEY DISEASE 1 0.0000
972 DECREASED APPETITE 3 0.0000
973 DRY MOUTH 1 0.0000
974 TREATMENT FAILURE 1 0.0000
975 MUSCULOSKELETAL STIFFNESS 1 0.0000
976 GASTROINTESTINAL DISORDER 1 0.0000
977 DEVICE ISSUE 1 0.0000
978 ADVERSE EVENT 1 0.0000
979 NASOPHARYNGITIS 2 0.0000
980 DRUG INTOLERANCE 1 0.0000
981 ALOPECIA 2 0.0000
982 SYNCOPE 1 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
984 RHEUMATOID ARTHRITIS 1 0.0000
985 EMOTIONAL DISTRESS 1 0.0000
986 RENAL FAILURE 1 0.0000